Research Peptides
A high-purity research blend studied in growth-hormone research. Available in 5mg/5mg, with every batch independently tested and dispatched from the UK.
A high-purity research blend studied in growth-hormone research. Available in 5mg/5mg, with every batch independently tested and dispatched from the UK.
CJC-1295 + Ipamorelin blend UK is Crown Peptides' research blend combining a short-acting GHRH analogue with Ipamorelin, available in 5mg+5mg strength for laboratory research.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
This blend combines CJC-1295 No DAC, a short-acting GHRH analogue, with [Ipamorelin], a selective growth-hormone secretagogue that acts through the ghrelin/GHSR pathway. The pairing is of research interest because the two components engage distinct upstream signalling systems involved in growth-hormone release, alongside related GHRH-axis peptides such as [CJC-1295 with DAC].
Laboratory research on the individual components examines complementary endocrine pathways. CJC-1295 No DAC is associated with GHRH-receptor signalling and pituitary response, while Ipamorelin is studied as the first selective growth-hormone secretagogue (Learn more) acting through the growth-hormone secretagogue receptor. Combined experimental models can therefore examine interactions between GHRH and ghrelin-receptor signalling.
Compound-level reference data. Batch-specific results appear on the Certificate of Analysis.
Work out concentration with the peptide calculatorCrown Peptides CJC-1295 + Ipamorelin Blend is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification.
The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.
Researchers working with the CJC-1295 + Ipamorelin blend may also be interested in [CJC-1295 with DAC], [Ipamorelin], [GHRP-6], [Sermorelin] and [Tesamorelin] — other growth-hormone-releasing peptides studied in the same endocrine research pathway.
It combines a short-acting GHRH analogue with Ipamorelin, a ghrelin-receptor growth-hormone secretagogue, supplied by Crown Peptides at 5mg+5mg.
They engage different upstream endocrine pathways, allowing researchers to study interactions between GHRH-receptor and GHSR signalling.
It indicates that the CJC component does not contain the Drug Affinity Complex used to prolong [CJC-1295 with DAC]'s persistence.
No. It is a mixture of two peptides, so one molecular formula or molecular weight does not represent the complete blend.
Use the product label and batch-specific Certificate of Analysis to confirm composition, identity and analytical results.
Every batch is published openly — identity, purity and batch number, with no account needed.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.
Disclaimer: All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, consumption, therapeutic, or diagnostic application. By purchasing, you confirm you are a qualified professional and legally permitted to handle these materials in compliance with all applicable laws and regulations. Misuse, resale for unauthorised purposes, or unlawful application is strictly prohibited. Crown Peptides UK disclaims all liability for improper use, handling, or regulatory non-compliance.